Cereno Scientific

Cereno Scientific company information, Employees & Contact Information

Cereno Scientific is pioneering treatments to enhance and extend life. The innovative pipeline offers disease-modifying drug candidates to empower people suffering from rare cardiovascular and pulmonary diseases to live life to the full. Cereno Scientific is advancing a pipeline that includes an HDACi portfolio with two drug candidates in clinical phase – CS1 in pulmonary arterial hypertension (PAH) and CS014 in idiopathic pulmonary fibrosis (IPF). The HDACi portfolio has an innovative disease-modifying approach to addressing the root mechanism of rare and fatal diseases, untapping the potential of epigenetic modulation in rare cardiovascular and pulmonary diseases. In preclinical stage, the pipeline comprises the drug candidate CS585, a novel prostacyclin (IP) receptor agonist, that has demonstrated the potential to significantly improve disease mechanisms relevant to cardiovascular disease. Cereno Scientific has the potential to deliver high treatment value to people that are suffering from rare cardiovascular and pulmonary diseases who today have unmet medical needs. The Company is headquartered in Gothenburg, Sweden, and has a US subsidiary; Cereno Scientific Inc. based in Kendall Square, Boston, Massachusetts, US. Cereno Scientific is listed on the Nasdaq First North (CRNO B).

Company Details

Employees
30
Address
Förändringens Gata 10, Gothenburg,västra Götaland County 43153,sweden
Industry
Biotechnology
Keywords
Los Angeles.
HQ
Gothenburg, Västra Götaland County
Looking for a particular Cereno Scientific employee's phone or email?

Cereno Scientific Questions

News

Podcast: Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases - Citeline News & Insights

Podcast: Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases Citeline News & Insights

Cereno Scientific to Participate at BIO-Europe Fall 2025 in Vienna - the Global BioPharma Partnering Event - TradingView

Cereno Scientific to Participate at BIO-Europe Fall 2025 in Vienna - the Global BioPharma Partnering Event TradingView

Is Cereno Scientific (STO:CRNO B) A Risky Investment? - simplywall.st

Is Cereno Scientific (STO:CRNO B) A Risky Investment? simplywall.st

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status - PharmTech

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status PharmTech

BioStock: Cereno Scientific advances on multiple fronts in Q1 - TradingView

BioStock: Cereno Scientific advances on multiple fronts in Q1 TradingView

A Swedish biotech is targeting thrombosis using the body's own defense system to prevent blood clots with lower risk of bleeding associated with current antithrombotic therapies - Endpoints News

A Swedish biotech is targeting thrombosis using the body's own defense system to prevent blood clots with lower risk of bleeding associated with current antithrombotic therapies Endpoints News

Cereno Scientific’s CBO about his new role - Biostock

Cereno Scientific’s CBO about his new role Biostock

Cereno Scientific appoints Dr. Rahul Agrawal as Chief Medical Officer and Head of R&D - Cision News

Cereno Scientific appoints Dr. Rahul Agrawal as Chief Medical Officer and Head of R&D Cision News

Status Report Cereno Scientific – Expanded potential in cardiovascular disease - Biostock

Status Report Cereno Scientific – Expanded potential in cardiovascular disease Biostock

Sten R. Sörensen, VD Cereno Scientific AB - Cision News

Sten R. Sörensen, VD Cereno Scientific AB Cision News

Top Cereno Scientific Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant